Giulia Manfredi1,2, Luís Midão2, Constança Paúl3,4, Clara Cena1, Mafalda Duarte3,5, Elísio Costa2. 1. Department of Pharmaceutical Science and Technology, University of Turin, Turin, Italy. 2. UCIBIO REQUIMTE, Porto4Ageing and Faculty of Pharmacy, University of Porto, Porto, Portugal. 3. Department of Behavioural Sciences, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal. 4. CINTESIS, Centre for Health Technology and Services Research, Porto, Portugal. 5. ISAVE, Higher Education Institute of Health of Alto Ave, Amares, Portugal.
Abstract
AIM: In the present study, we aimed to update the data of frailty status in the European community-dwelling population of older adults, based on the latest data released (wave 6) of the Survey of Health, Aging and Retirement in Europe database, and to study the impact of each criterion on frailty assessment. METHODS: Frailty status was assessed applying a version of the Fried phenotype operationalized for the Survey of Health, Aging and Retirement in Europe. We included all participants who answered all the questions used in a frailty assessment and who disclosed their sex and, furthermore, who were aged ≥50 years. Our final sample was 60 816 individuals. Of these, the mean age was 67.45 ± 9.71 years; 38 497 (56.4%) were women. RESULTS: The overall prevalence of pre-frailty was 42.9% (ranging from 34.0% in Austria to 52.8% in Estonia), and frailty was 7.7% (ranging from 3.0% in Switzerland to 15.6% in Portugal). Pre-frailty and frailty prevalence increased along with age, and were more frequent among women. Regarding the five criteria considered on frailty assessment, exhaustion seems to be the criterion that contributes most to frailty status, followed by low activity, weakness, loss of appetite and slowness. CONCLUSIONS: With this work, we showed that >50% of the European population aged >50 years are pre-frail/frail, which must be considered when designing interventions to reduce/postpone/mitigate the progression of this condition, thus reducing the burden associated with it. Geriatr Gerontol Int 2019; 19: 723-729.
AIM: In the present study, we aimed to update the data of frailty status in the European community-dwelling population of older adults, based on the latest data released (wave 6) of the Survey of Health, Aging and Retirement in Europe database, and to study the impact of each criterion on frailty assessment. METHODS: Frailty status was assessed applying a version of the Fried phenotype operationalized for the Survey of Health, Aging and Retirement in Europe. We included all participants who answered all the questions used in a frailty assessment and who disclosed their sex and, furthermore, who were aged ≥50 years. Our final sample was 60 816 individuals. Of these, the mean age was 67.45 ± 9.71 years; 38 497 (56.4%) were women. RESULTS: The overall prevalence of pre-frailty was 42.9% (ranging from 34.0% in Austria to 52.8% in Estonia), and frailty was 7.7% (ranging from 3.0% in Switzerland to 15.6% in Portugal). Pre-frailty and frailty prevalence increased along with age, and were more frequent among women. Regarding the five criteria considered on frailty assessment, exhaustion seems to be the criterion that contributes most to frailty status, followed by low activity, weakness, loss of appetite and slowness. CONCLUSIONS: With this work, we showed that >50% of the European population aged >50 years are pre-frail/frail, which must be considered when designing interventions to reduce/postpone/mitigate the progression of this condition, thus reducing the burden associated with it. Geriatr Gerontol Int 2019; 19: 723-729.
Authors: Hélio José Coelho-Júnior; Marco Carlos Uchida; Anna Picca; Roberto Bernabei; Francesco Landi; Riccardo Calvani; Matteo Cesari; Emanuele Marzetti Journal: Aging Clin Exp Res Date: 2021-02-15 Impact factor: 3.636
Authors: Anh Trung Nguyen; Long Hoang Nguyen; Thanh Xuan Nguyen; Huong Thi Thu Nguyen; Tam Ngoc Nguyen; Hai Quang Pham; Bach Xuan Tran; Carl A Latkin; Cyrus S H Ho; Roger C M Ho; Thang Pham; Huyen Thi Thanh Vu Journal: Int J Environ Res Public Health Date: 2019-10-12 Impact factor: 3.390
Authors: A C Nixon; T J Wilkinson; H M L Young; M W Taal; N Pendleton; S Mitra; M E Brady; A P Dhaygude; A C Smith Journal: BMC Nephrol Date: 2020-09-23 Impact factor: 2.388